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Background: Overweight and obesity in adolescents are associated with a
subsequent increased mortality due to cardiovascular disease in adulthood.
The reactive hyperemia-peripheral artery tonometry (RH-PAT) is a
non-invasive method for endothelial function assessment.
Objective: The goal of this study is to investigate endothelial function as
assessed with the RH-PAT in adolescents with overweight or obesity.
Methods: In 27 adolescents with overweight or obesity (16 males, 11 females)
and 25 control subjects (12 males, 13 females) (age 12–20 yr) RH-PAT score
and baseline pulse amplitude were measured after an overnight fast.
Confounding risk factors for endothelial dysfunction, including smoking and
diabetes mellitus were excluded.
Results: RH-PAT score was lower in adolescents with overweight or obesity
compared to healthy controls, whereas their baseline pulse amplitude was
higher (p = 0.027 and p< 0.0001, respectively). A significantly positive
correlation was seen between baseline pulse amplitude and body mass index
standard deviation score in the group with overweight or obese subjects.
Conclusions: Endothelial dysfunction, measured by lower RH-PAT score and
higher baseline pulse amplitude, was present in overweight adolescents.
Interestingly, we also report for the first time in the literature a significant
difference in baseline pulse amplitude between overweight adolescents
compared to their peers.
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Childhood overweight and obesity have become major
public health issues. According to the International
Obesity Taskforce, the percentage of overweight
children in Belgium reaches 10−15%, and obesity
2% (http://www.iotf.org/childhoodobesity.asp). Over-
weight in childhood is associated with an increased
mortality due to cardiovascular disease in adulthood,
independent of adult weight (1). In the study by Franks
et al., a positive association between childhood obesity
and the risk of premature death, defined as death
before 55 yr of age, was shown. Children in the highest
quartile of age-standardized and sex-standardized
body mass index (BMI) had significantly higher rates of
premature death than did children in the lowest quar-
tile (2). Endothelial dysfunction is the suggested link
between pediatric patients with overweight or obesity
and the development of premature cardiovascular dis-
ease (CVD). Indeed, in adult studies, it has been shown
that endothelial dysfunction precedes atherosclerotic
plaque formation. Early detection of this process
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may have therapeutic and prognostic implications (3).
Endothelial dysfunction is described as the inability
of the artery to sufficiently dilate in response to
an appropriate endothelial stimulus. Endothelial
function is a subclinical measure for evaluating early
vascular changes in patients with increased future
cardiovascular risk. Assessment of digital hyperemia
is gaining prominence as a non-invasive tool to test
endothelial function and has been evaluated in the
pediatric population (4–8). Using reactive hyperemia-
peripheral artery tonometry (RH-PAT), we evaluated
endothelial function in a young adolescent group with
overweight or obesity compared to a normal weight
control group. The goal of this study was to determine
whether a significant difference in RH-PAT score or
baseline pulse amplitude was found in adolescents
with overweight or obesity as compared to controls.
Methods
Study participants
Thirty-one adolescents with overweight (17 males and
14 females) and 27 healthy age- and sex-matched
control subjects (13 males and 14 females) were
recruited from our outpatient clinic between January
2009 and March 2013. All patients who participated
in this study were Caucasian and aged 12−20 yr.
Overweight and obesity were defined by using the age-
adjusted BMI cutoff points suggested by Cole et al. in
children under the age of 18 (9). At the age of 18 yr,
the adult cutoff points were used (BMI ≥ 25 kg/m2
for overweight and BMI ≥ 30 kg/m2 for obesity). All
subjects were non-smokers. Controls were excluded
when there was a familial history of premature CVD
(having first- or second-degree relatives with premature
CVD). Two children from the control group were
excluded from the study, resulting in 25 control subjects
(12 males and 13 females). Exclusion criteria for the
overweight subjects included a familial history of
premature CVD or a personal history of overweight,
but not longer reaching the overweight criteria on the
testing day thanks to lifestyle changes. Four patients
needed to be excluded resulting in 27 overweight
subjects (16 males and 11 females).
Study design
Overweight and obese patients from the outpatient
clinic at the University Hospitals Leuven, and their
parents, received verbal and written information
before providing written consent. The control group
was already recruited in our previous study and
consisted of friends or family of patients with type
1 diabetes (8). The study was approved by the
Ethical Review Board of the University Hospitals.
The study was registered as NCT01267591. Reactive
hyperemia-peripheral artery tonometry (RH-PAT)
endothelial function was assessed using the Endo-
PAT device (Itamar Medical Ltd., Caesara, Israel).
All measurements were performed in the same noise-
and temperature-controlled room, in fasting state in
the morning. The patient was placed in a comfortable
position with the hands at heart level with the fingers
hanging freely to avoid muscular activity. They were
instructed to remain quiet during the measurements.
Two plethysmographic registration probes were placed
on both index fingers. After 5 min of baseline
measurement, arterial flow to the non-dominant arm
was occluded for 5 min using a blood pressure cuff
inflated to 40 mmHg above systolic pressure. After
the 5-min occlusion, the cuff deflated rapidly to allow
for reactive or flow-mediated hyperemia. Pulse wave
amplitudes were recorded for at least 5 min after the
cuff is deflated. Owing to the concurrent signal from the
contralateral finger, the method corrects for changes
in systemic vascular tone. The probes were connected
to a computer for online registration of all recordings.
A specialized software program calculated the ratio of
the average blood volume before and after occlusion
in both fingers to know the RH-PAT score (10).
The RH-PAT score was calculated as the ratio of
the average pulse wave amplitude during the 1-min
period starting 60 s after cuff deflation divided by the
average pulse wave amplitude of a 210-s preocclusion
baseline period. Lower RH-PAT scores reflect greater
endothelial dysfunction. Following RH-PAT testing,
height (without shoes), weight (in underwear, without
shoes), blood pressure (BP), and Tanner score were
recorded and blood was obtained in fasting condition
for lipid profile, blood glucose, insulin, and hemoglobin
A1c (HbA1c). Insulin resistance (IR) or a decreased
sensitivity or responsiveness to metabolic actions
of insulin was measured by the homeostasis model
assessment (HOMA), fasting glucose/insulin ratio
(FGIR), and quantitative insulin sensitivity check
index (QUICKI). The HOMA index was calculated
as the product of fasting glucose concentration (in
mmol/L) times fasting insulin concentration (in mU/L)
divided by 22.5 (11). Increases in HOMA and insulin
values and decreases in FGIR reflect insulin resistance.
QUICKI was derived by calculating the inverse of
the sum of logarithmically expressed fasting glucose
(in mg/dL) and insulin concentrations (in mU/L) (12).
As insulin concentrations increase, QUICKI values
decrease.
Statistical methods
All data are presented by the median and interquartile
range. The primary endpoints of the study were the
RH-PAT score and the baseline pulse amplitude.
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Other variables were analyzed as secondary endpoints.
The characteristics, RH-PAT values and baseline
pulse amplitudes in overweight cases were compared
to controls (unpaired analysis, Mann–Whitney U
test). Correlations (rank) between RH-PAT and BMI
standard deviation score (SDS) were studied and
between baseline pulse amplitude and BMI SDS. A
p value below 0.05 was considered to be statistically
significant. The statistical analysis was performed with
the program MedCalc® version 11.4.3 (Mariakerke,
Ghent, Belgium).
Results
Baseline characteristics
We refer to Table 1 for an overview of the baseline
characteristics of the study patients. No difference
was observed in variables like age, fasting glucose
levels, or Tanner score. As expected, the group with
overweight or obesity individuals had significantly
higher BMI values (p< 0.0001) compared to controls.
The lipid profile was more atherogenic in the subjects
with overweight having statistically significantly
higher triglycerides [72.0 mg/dL (64.0−121.0) vs.
64.0 mg/dL (43.8–81.8), p = 0.0164], a significantly
higher low-density lipoprotein (LDL) level [92.0 mg/dL
(76.3–102.8) vs. 76.0 mg/dL (64.5−89.3), p = 0.006]
and a significantly lower high-density lipoprotein
(HDL) level [45.0 mg/dL (41.3–49.8) vs. 58.0 mg/dL
(49.8–63.8), p = 0.0012]. Systolic blood pressure
differed significantly between the two groups with
a statistically significant higher systolic BP SDS
[1.6 (1.0–2.2) vs. 0.9 (0.08–1.5), p = 0.007) in
overweight and obese adolescents. Overweight or obese
adolescents had higher insulin values compared to
controls, but the results were not significant.
RH-PAT and baseline pulse amplitude
Children with overweight or obesity (n = 27) had
overt endothelial dysfunction as evidenced by lower
median RH-PAT scores vs. controls [1.51 (1.27–1.90)
vs. 1.88 (1.67–2.42), p = 0.027] and higher baseline
pulse amplitude [416.30 (360.3–675.7) vs. 145.29
(52.3–300.2), p< 0.0001]. The data of this analysis
are shown in Fig. 1.
Analysis of RH-PAT and baseline pulse amplitude
as continuous variables
Continuous analysis of RH-PAT scores in function of
different continuous variables showed a significantly
positive correlation with age [r = 0.4 (0.03–0.68),
p = 0.035] and Tanner score [r = 0.45 (0.05–0.73),
p = 0.03]. A significant negative correlation was
Fig. 1. Box plot of reactive hyperemia-peripheral artery tonometry
(RH-PAT) score in controls vs. subjects with overweight or obesity,
p = 0.027 (A) and baseline pulse amplitude in controls vs. subjects
with overweight or obesity, p< 0.0001 (B).
seen between RH-PAT and diastolic BP SDS
[r =−0.5 (−0.74 to −0.15), p = 0.008]. The correlation
between RH-PAT and systolic BP SDS was nearly
significant [r =−0.38 (−0.66 to −0.0005), p = 0.05].
No correlation was found between RH-PAT and the
other variables, such as BMI SDS, glucose, insulin,
HbA1c, total cholesterol, LDL, HDL, or triglycerides.
A significantly positive correlation was found
between baseline pulse amplitude and BMI SDS
[r = 0.39 (0.006–0.67), p = 0.047] in the group with
overweight or obese subjects (Fig. 2). The other
variables (age, Tanner score, diastolic or systolic BP,
glucose, insulin, HbA1c, total cholesterol, LDL, HDL,
or triglycerides) were not statistically significant.
Discussion
In this cross-sectional study, we measured endothelial
function by RH-PAT score and baseline pulse
amplitude. Adolescents with overweight or obesity
Pediatric Diabetes 2014 3
Pareyn et al.
Table 1. Demographic and biochemical characteristics of the study patients
Characteristics Controls (n=25) Overweight (n=27) p value
Male gender (n) 12 16 —
Age (yr) 15.5 (13.9–16.2) 14.7 (13.0–16.4) 0.61
BMI SDS 0 [−0.3 to 0.5) 2.6 (2.0–3.0) <0.0001
Obesity/n — 16/27 —
Tanner 4 (3–5) 5 (3–5) 0.65
Systolic BP SDS 0.9 (0.08–1.5) 1.6 (1.0–2.2) 0.007
Diastolic BP SDS 0.1 (−0.4 to 0.5) 0.2 (−0.2 to 1.0) 0.73
Glucose (mg/dL) 92.0 (85.0–98.5) 91.0 (82.3–94.0) 0.39
Insulin (mU/L) 10.4 (7.7–14.8) 14.6 (9.1–24.3) 0.07
FGIR 8.5 (6.3–11) 6.4 (3.8–10.1) 0.06
QUICKI 0.34 (0.32–0.35) 0.32 (0.30–0.34) 0.12
HOMA 2.28 (1.68–3.59) 3.39 (2.03–5.60) 0.10
HbA1c (%) 5.3 (5.2–5.4) 5.4 (5.2–5.5) 0.16
Total cholesterol (mg/dL) 146.0 (130.0–164.0) 159.0 (136.0–166.5) 0.21
LDL (mg/dL) 76.0 (64.5–89.3) 92.0 (76.3–102.8) 0.006
HDL (mg/dL) 58.0 (49.8–63.8) 45.0 (41.3–49.8) 0.0012
Triglycerides (mg/dL) 64.0 (43.8–81.8) 72.0 (64.0–121.0) 0.0164
BMI, body mass index; BP, blood pressure; FGIR, fasting glucose/insulin ratio; HDL, high-density lipoprotein; HbA1c,
Hemoglobin A1c; HOMA, homeostatic model assessment; LDL, low-density lipoprotein; QUICKI, quantitative insulin sensitivity
check index; SDS; standard deviation score.
All values reported as median (P25–P75).
Fig. 2. Significantly positive correlation between baseline pulse
amplitude and BMI SDS in the group with overweight or obese
subjects, r = 0.39 (0.006−0.67), p = 0.047.
had a significantly lower RH-PAT score as compared
to controls, whereas their baseline pulse amplitude
was higher. RH-PAT uses fingertip plethysmography
probes to measure the changes in pulse wave amplitude
observed before and after the period of reactive
hyperemia (4). Endothelium-mediated changes in
vascular tone after occlusion of the brachial artery are
reflecting a downstream hyperemic response, which
is a measure for arterial endothelial function. An
unequivocal theory about the underlying mechanism of
the RH-PAT is lacking. It is known that the provoked
endothelium-dependent flow-mediated vasodilatation
after removing the occlusion is partly (60%) mediated
by endothelial release of nitric oxide (NO) (13). In
adults, the Framingham cohort study described a
direct relation between several cardiovascular risk
factors such as tobacco use, cholesterol, BMI, diabetes
mellitus, and baseline pulse amplitude and an inversely
association with RH-PAT score (7). Previous studies of
early vascular changes in the pediatric obese population
have reported inconsistent findings. Only two previous
studies have used the RH-PAT score to demonstrate
alterations in endothelial function in adolescents with
overweight. Our results are consistent with the data
from the study of Mahmud et al. They showed a
significantly lower RH-PAT score in obese adolescents
with insulin resistance in relation to healthy controls,
indicative of impaired endothelial function (14). In
contrast, in the study of Tryggestad et al., the RH-
PAT score did not differ between the normal weight
and overweight group (15). In the control group, the
RH-PAT score was positively correlated with age.
This relationship was not evident in the overweight
group although the RH-PAT score tended to be lower
in obese children at the older end of the age range
studied. The results of this study suggested that the
RH-PAT score might begin to decline in overweight
adolescents after the age of 15 yr as there was a trend
in that direction. This might explain the discordance
with our data, as our cohort was older than the
cohort in the study of Tryggestad et al. (14.7 vs.
13.9 yr). If this hypothesis could be confirmed, it would
suggest that exposure to the effects of obesity for
several years might be required before microvascular
reactive hyperemia is adversely affected. This would be
consistent with the Framingham cohort study which
describes an inverse relation between the RH-PAT
score and BMI in adults (7). In the study of Mahmud
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et al., however, the overweight group had already lower
RH-PAT scores compared to controls at a mean age
of 13.4 yr old. This could be explained by the higher
absolute BMI in this group compared to our group
(34.8 vs. 29.5 kg/m2) and the negative association
between BMI and the RH-PAT score, as clearly
described by Mahmud et al. (14). Further research
on the relation between age and RH-PAT score in
overweight subjects would be interesting. Additionally,
we observed higher baseline pulse amplitude in obese
and overweight individuals compared to those of
normal weight and a significantly positive correlation
between baseline pulse amplitude and BMI SDS. To
our knowledge, differences in baseline pulse amplitude
in obese adolescents have not been previously reported.
Our group, however, described similar findings in
adolescents with type 1 diabetes, with significantly
higher baseline pulse amplitude in the diabetes group
vs. the control group (8). These findings were consistent
with the data from the study of Hamburg et al. in adults
(7). They observed that baseline pulse amplitude was
directly related to several cardiovascular risk factors,
including hypertension, diabetes mellitus, overweight,
and smoking. Baseline pulse amplitude was highly
dependent on digital blood flow and sympathetic tone,
as evidenced by a marked reduction in digital pulse
amplitude after the administration of phenylephrine,
an α-adrenergic vasoconstrictor agent (13). Decreased
digital microvessel tone, increased blood flow, and
altered microvascular structure might all contribute
to this higher resting pulse amplitude. Our findings
were consistent with the study of Mitchell et al. that
showed an association between obesity in adults and
a higher resting blood flow in the brachial artery
(16). The presence of increased basal blood flow
represents hyperperfusion, which might contribute to
microvascular hypertension and microvessel damage
in obese individuals.
IR might be a proposed link between obesity
and vascular stiffness (17). In our study, insulin
levels were increased in the overweight group,
although not significantly. This could be due to
the relatively small sample size that limits the
power of the study. Hemodynamic actions of
insulin include both vasodilator and vasoconstrictor
effects. Insulin stimulates the production of NO
in vascular endothelium, while IR may impair
insulin-stimulated production of NO. Furthermore,
insulin also stimulates the release of endothelin that
opposes vasodilator effects of NO. Thus, the net
vasoactive effect of insulin may depend on the balance
between NO-dependent and NO-independent actions
elicited. As a result, IR is accompanied by selective
impairment of insulin action in the vasculature.
Consequently, compensatory hyperinsulinemia that
serves to maintain glucose homeostasis also favors
prohypertensive effects of insulin (17). In our study,
BP, especially systolic BP, was higher in the group
of overweight and obese adolescents. This might also
have an important effect on the distal microcirculation.
Some limitations of the study are acknowledged.
First, our study has a relatively small sample size
that limits the power of the study. Second, we do
not specifically analyze visceral adiposity, known as
a predictor of cardiovascular risk in adults. Finally,
the RH-PAT technique also has its limitations. An
unequivocal theory about the underlying mechanism
is lacking. There is some uncertainty about the
relative importance of endothelium-dependent and
endothelium-independent vasodilatation in the RH-
PAT response. The vascular bed (and thus RH-PAT)
is highly responsive to sympathetic tone and thus to
external influences, such as anger, depression, and
anxiety (18). There is also a high cost associated with
the finger probes as each probe can only be used once.
In conclusion, overweight and obesity are globally
increasing health problems for young people. Using
RH-PAT, we evaluated endothelial function in this
risk group compared to a normal weight control group.
Our study showed a significantly lower RH-PAT score
in adolescents with overweight or obesity as compared
to controls, whereas their baseline pulse amplitude was
higher. Moreover, a significantly positive correlation
was found between baseline pulse amplitude and BMI
SDS. Considering that the endothelial dysfunction is
a reversible process, further research is required about
therapeutic life style effects on RH-PAT score and
baseline pulse amplitude.
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